MacroGenics
MGNX
130 hedge funds and large institutions have $796M invested in MacroGenics in 2019 Q2 according to their latest regulatory filings, with 16 funds opening new positions, 57 increasing their positions, 37 reducing their positions, and 39 closing their positions.
176% more call options, than puts
Call options by funds: $4.98M | Put options by funds: $1.81M
54% more repeat investments, than reductions
Existing positions increased: 57 | Existing positions reduced: 37
5.48% more ownership
Funds ownership: 90.6% → 96.08% (+5.5%)
0% more capital invested
Capital invested by funds: $795M → $796M (+$339K)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
17% less funds holding
Funds holding: 157 → 130 (-27)
59% less first-time investments, than exits
New positions opened: 16 | Existing positions closed: 39
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Invesco
Atlanta,
Georgia
|
+$76.7M |
| 2 |
BG
Bellevue Group
Kuesnacht,
Switzerland
|
+$61.9M |
| 3 |
Ameriprise
Minneapolis,
Minnesota
|
+$34.3M |
| 4 |
Millennium Management
New York
|
+$24.5M |
| 5 |
State Street
Boston,
Massachusetts
|
+$20.6M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Point72 Asset Management
Stamford,
Connecticut
|
-$19M |
| 2 |
Citadel Advisors
Miami,
Florida
|
-$10.1M |
| 3 |
Franklin Resources
San Mateo,
California
|
-$8.26M |
| 4 |
Renaissance Technologies
New York
|
-$6.86M |
| 5 |
D.E. Shaw & Co
New York
|
-$6.44M |
MGNX Hedge Fund Activity: Q2 2019 in Review
130 of the 4,604 institutional investors tracked by Wall St. Rank reported a position in MacroGenics (MGNX) for Q2 2019, worth a combined $796M — up 0.04% from $795M a quarter earlier.
Sellers outnumbered buyers: 39 funds closed out of MGNX and 16 opened new positions — a net loss of 23 holders — while 37 trimmed existing stakes and 57 added.
The largest buyer was Invesco, adding an estimated $76.7M. The largest seller was Point72 Asset Management, cutting an estimated $19M.
- 130 institutional investors held MacroGenics (MGNX) as of Q2 2019, down from 157 in Q1 2019.
- Funds reported $796M of MacroGenics stock for Q2 2019, up 0.04% quarter-over-quarter.
- 16 funds opened new MacroGenics positions in Q2 2019 and 39 closed out, a net change of -23 holders.
- The largest MacroGenics buyer in Q2 2019 was Invesco, an estimated $76.7M added.
- The largest MacroGenics seller in Q2 2019 was Point72 Asset Management, an estimated $19M sold.
Based on aggregated 13F filings for Q2 2019.